Terms: = Endocrine gland cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Treatment
69 results:
1. NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1.
Zhang Z; Song B; Wei H; Liu Y; Zhang W; Yang Y; Sun B
Drug Resist Updat; 2024 Mar; 73():101040. PubMed ID: 38228036
[TBL] [Abstract] [Full Text] [Related]
2. Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in n-myc-activated neuroblastoma.
Chen C; Wu J; Hicks C; Lan MS
Cell Signal; 2023 Sep; 109():110753. PubMed ID: 37301315
[TBL] [Abstract] [Full Text] [Related]
3. A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
Bauer TM; Moore KN; Rader JS; Simpkins F; Mita AC; Beck JT; Hart L; Chu Q; Oza A; Tinker AV; Imedio ER; Kumar S; Mugundu G; Jenkins S; Chmielecki J; Jones S; Spigel D; Fu S
Target Oncol; 2023 Jul; 18(4):517-530. PubMed ID: 37278879
[TBL] [Abstract] [Full Text] [Related]
4. GSK2801 Reverses Paclitaxel Resistance in Anaplastic Thyroid cancer Cell Lines through mycn Downregulation.
Molteni E; Baldan F; Damante G; Allegri L
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983070
[TBL] [Abstract] [Full Text] [Related]
5. Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.
Ho GY; Kyran EL; Bedo J; Wakefield MJ; Ennis DP; Mirza HB; Vandenberg CJ; Lieschke E; Farrell A; Hadla A; Lim R; Dall G; Vince JE; Chua NK; Kondrashova O; Upstill-Goddard R; Bailey UM; Dowson S; Roxburgh P; Glasspool RM; Bryson G; Biankin AV; ; Cooke SL; Ratnayake G; McNally O; Traficante N; ; DeFazio A; Weroha SJ; Bowtell DD; McNeish IA; Papenfuss AT; Scott CL; Barker HE
Cancer Res; 2022 Dec; 82(23):4457-4473. PubMed ID: 36206301
[TBL] [Abstract] [Full Text] [Related]
6. Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature.
Montalto S; Sertorio F; Podda M; Sorrentino S; Di Cataldo A; Provenzi M; Nonnis A; D'Ippolito C; Corrias MV; De Bernardi B
Pediatr Hematol Oncol; 2022 Aug; 39(5):441-452. PubMed ID: 35139733
[TBL] [Abstract] [Full Text] [Related]
7. Chromosome 10 abnormality predicts prognosis of neuroblastoma patients with bone marrow metastasis.
Jiang CY; Xu X; Jian BL; Zhang X; Yue ZX; Guo W; Ma XL
Ital J Pediatr; 2021 Jun; 47(1):134. PubMed ID: 34108028
[TBL] [Abstract] [Full Text] [Related]
8. Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma.
Geleta B; Park KC; Jansson PJ; Sahni S; Maleki S; Xu Z; Murakami T; Pajic M; Apte MV; Richardson DR; Kovacevic Z
FASEB J; 2021 Feb; 35(2):e21347. PubMed ID: 33484481
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of NDRG2 promotes the therapeutic effect of pazopanib on ovarian cancer.
Cui Y; Shen G; Ma L; Lv Q
J Recept Signal Transduct Res; 2021 Dec; 41(6):546-552. PubMed ID: 33050824
[TBL] [Abstract] [Full Text] [Related]
10. The feasibility of adrenal-sparing surgery in bilateral adrenal neuroblastoma.
Chui CH; Chang KTE
J Pediatr Surg; 2020 Dec; 55(12):2836-2839. PubMed ID: 32703624
[TBL] [Abstract] [Full Text] [Related]
11. NDRG2 gene expression pattern in ovarian cancer and its specific roles in inhibiting cancer cell proliferation and suppressing cancer cell apoptosis.
Kang F; Wang Y; Luo Y; Zhang Y
J Ovarian Res; 2020 Apr; 13(1):48. PubMed ID: 32345304
[TBL] [Abstract] [Full Text] [Related]
12. NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane permeabilization.
Sahni S; Gillson J; Park KC; Chiang S; Leck LYW; Jansson PJ; Richardson DR
Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129625. PubMed ID: 32335136
[TBL] [Abstract] [Full Text] [Related]
13. EWSR1(22q12) Translocation Positive Pediatric Adrenal Tumor with Loss of 1p, 11q, and Unbalanced Gain of 17q: Neuroblastoma or Ewing Sarcoma?
Azizoglu M; Demirsoy U; Kulac I; Aktas S; Çorapcioglu F
Fetal Pediatr Pathol; 2021 Dec; 40(6):717-722. PubMed ID: 32242756
[No Abstract] [Full Text] [Related]
14. UNC5B-AS1 promoted ovarian cancer progression by regulating the H3K27me on NDRG2 via EZH2.
Wang H; Su H; Tan Y
Cell Biol Int; 2020 Apr; 44(4):1028-1036. PubMed ID: 31903696
[TBL] [Abstract] [Full Text] [Related]
15. GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
Cournoyer S; Addioui A; Belounis A; Beaunoyer M; Nyalendo C; Le Gall R; Teira P; Haddad E; Vassal G; Sartelet H
BMC Cancer; 2019 Oct; 19(1):1018. PubMed ID: 31664947
[TBL] [Abstract] [Full Text] [Related]
16. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
Han L; Zan Y; Huang C; Zhang S
Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
[TBL] [Abstract] [Full Text] [Related]
17. Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer.
Emmanouilidi A; Fyffe CA; Ferro R; Edling CE; Capone E; Sestito S; Rapposelli S; Lattanzio R; Iacobelli S; Sala G; Maffucci T; Falasca M
J Exp Clin Cancer Res; 2019 May; 38(1):191. PubMed ID: 31088502
[TBL] [Abstract] [Full Text] [Related]
18. Killer-cell immunoglobulin-like receptor ligand mismatch cord blood transplantation in high-risk neuroblastoma.
Matsuno R; Toyama D; Akiyama K; Isoyama K; Shiozawa E; Yamamoto S
Pediatr Int; 2019 Jun; 61(6):566-571. PubMed ID: 30974480
[TBL] [Abstract] [Full Text] [Related]
19. Neuroblastoma of the Iris in Children.
Ocak S; Kebudi R; Cebeci Z; Buyukbabani N; Bilgic B; Tuncer S
J Pediatr Ophthalmol Strabismus; 2019 Feb; 56():e12-e16. PubMed ID: 30747977
[TBL] [Abstract] [Full Text] [Related]
20. Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China.
Yao W; Li K; Dong KR; Zheng S; Xiao XM
World J Pediatr; 2019 Apr; 15(2):148-152. PubMed ID: 30446974
[TBL] [Abstract] [Full Text] [Related]
[Next]
